Spontaneous animal model, ddY mouse, for studying the pathogenesis and treatment in patients with immunoglobulin A nephropathy.

Abstract

Immunoglobulin (Ig)A nephropathy has the highest incidence among the various forms glomerulonephritis in the world. The initiating and progressive factors in patients with IgA nephropathy are still obscure. Although there is no specific treatment for patients with IgA nephropathy at present, more clinical trials of new treatments are warranted for such patients. Therefore, it is necessary to clarify those factors and to develop more effective drugs using a spontaneous animal model, the ddY mouse, in the future.

• Authors: Yasuhiko Tomino
• Journal: Nephrology (Carlton, Vic.) (Nephrology (Carlton)) Vol. 15 Issue 1 Pg. 1-6 (Feb 2010) ISSN: 1440-1797 [Electronic] Australia
• PMID: 20377762 (Publication Type: Journal Article, Review)

Topics

• Animals
• Clinical Trials as Topic
• Disease Models, Animal
• Glomerulonephritis, IGA (etiology, therapy)
• Humans
• Mice